Trial Category: Endocrinology/Gastroenterology

Optimal Therapeutic Dosing Scheme in Thyroid Hormone Replacement After Thyroidectomy for Benign Disease: Retrospective Review and Validation Study

View Details →

A 26-Week, Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase 3 Trial with a 26-Week Safety Extension Period Evaluating the Safety and Efficacy of Dapagliflozin 5 and 10 mg, and Saxagliptin 2.5 and 5 mg in Pediatric Patients with Type 2 Diabetes Mellitus Who Are Between 10 and Below 18 Years of Age

View Details →

Minimizing narcotic analgesia after endocrine surgery

View Details →

Adrenal Disease Database

View Details →

Impact of home telemonitoring on the management of patients with diabetes and hypertension

View Details →

The Effectiveness of Bariatric Surgery on Metabolic Profiles in a Hispanic Population including Effectiveness of Early Preoperative Weight Loss as a Predictor of the Surgical Success

View Details →

Osteoporosis-Related Post-Fracture Care Application Development and Testing

View Details →

A Nine Week Open-Label Crossover Study of Insulin Degludec (U100 and U200) and Insulin Glargine (U300) to Observe and Compare the Incidence of Hypoglycemia when Basal Insulin Administration is Changed from Evening to Morning.

View Details →

Impact of Accountable Care Organizations model implementation in the RGV: A retrospective study on acute cholecystitis

View Details →

A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients with Moderately to Severely Active Ulcerative Colitis LUCENT 1

View Details →